Sanofi posts stronger-than-expected result in Q4, eyes more cost cuts

Topics Sanofi  | Sanofi India | Q3 results


PARIS (Reuters) - Sanofi said on Friday it aimed to grow earnings per share this year after it posted stronger-than-expected results in the fourth quarter, and the drugmaker hiked its cost cutting target as part of a bid to boost margins. The French company, which stunned investors last year with the delay of a COVID-19 vaccine candidate, confirmed an operating income margin target of 30% for 2022 and set itself a goal to improve it to more than 32% three years later.

It stood at 27.1% in 2020. Sanofi, which is cutting just under.....

This article is no longer available in our repository.

There could be multiple reasons for this.